Table 9.
The number of patients with disrupted hematological and nephrological paremeters pre- and post-treatment (patients are categorized into grades G1–G5 according to the NCI CTCAE criteria).
| Pre-Treatment | Post-Treatment | ||||||
|---|---|---|---|---|---|---|---|
| G1 | G2 | G1 | G2 | G3 | Total pre-treatment (%) | Total post-treatment (%) | |
| Leukopenia | 1 | 0 | 5 | 1 | 0 | 1/42 (2.4) | 6/42 (14.3) |
| Neutropenia | 0 | 0 | 1 | 0 | 0 | 0/42 (0) | 1/42 (2.4) |
| Lymphopenia | 2 | 2 | 7 | 2 | 0 | 4/42 (9.5) | 9/42 (21.4) |
| Anemia | 6 | 1 | 5 | 2 | 1 | 7/42 (16.7) | 8/42 (19) |
| Thrombocytopenia | 2 | 0 | 3 | 0 | 0 | 2/42 (4.8) | 3/42 (7.14) |
| Creatinine increase | 6 | 0 | 5 | 0 | 0 | 6/40 (15) | 5/40 (12.5) |
| GFR decrease | 17 | 7 | 15 | 7 | 0 | 24/40 (60) | 22/40 (55) |